心房細動 高齢者にもLAAOは長期的に有効：J Am Coll Cardiol EP. 2023;9(5):669-676.
Left Atrial Appendage Occlusion in the Elderly: Insights From PROTECT-AF, PREVAIL, and Continuous Access Registries Sula...
2023-06
心房細動 心房細動 PREVAIL Trial : NVAFに対するLAA closureの安全性と有効性 / J Am Coll Cardiol. 2014;64(1):1-12.
Prospective randomized evaluation of the WATCHMAN Left Atrial Appendage Closure device in patients with atrial fibrillat...
僧帽弁 MVP vs MVR for Ischemic MRの2年予後 : N Engl J Med 2016; 374:344-353
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation Daniel Goldstein, M.D., et al., for the ...
TXA TXAが出血と輸血の減少に繋がることは確からしい。痙攣は？: N Engl J Med 2017; 376:136-148
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery Paul S. Myles, M.P.H., M.D., et al., for the ATACAS Inves...
TXA TXA高容量と低容量で差はない？: Eur J Anaesthesiol. 2014 Sep;31(9):491-8.
Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a random...
TXA TXAは低容量と高容量で効果に差がない？ : BMC Anesthesiol. 2021 Feb 2;21(1):33.
Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular c...
心房細動 5年間の長期予後 from PREVAIL Trial and PROTECT AF Trial
5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
弁膜症 PARTNER3 Trial : TAVRのの有用性 for 低risk患者 / N Engl J Med 2019; 380:1695-1705
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients Michael J. Mack, M.D., et al...
弁膜症 PARTNER2 Trial : N Engl J Med 2016; 374:1609-1620
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients Martin B. Leon, M.D., et al., for the P...
弁膜症 PARTNER Trial : N Engl J Med 2010; 363:1597-1607
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery Martin B. Leon, M.D.,...